CDMO Network
operates a neutral, curated platform accelerating biomanufacturing partnerships by mapping real capabilities and coordinating execution across discovery, development and GMP; its live "active CDMO programs" directory (June 2026) lists anonymized sponsor demand by modality, scope and development stage.
- Country
- United States
capacity-matching
us
Coverage
| CN | EU | US | |
|---|---|---|---|
| market-access-commercial | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Fermentation-capacity brokerage | market-access-commercial | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.